Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1946 2
1947 2
1948 5
1949 1
1951 3
1952 7
1953 5
1955 3
1962 1
1965 1
1966 1
1968 2
1969 1
1971 2
1972 2
1973 7
1974 3
1975 9
1976 11
1977 16
1978 18
1979 16
1980 10
1981 19
1982 13
1983 24
1984 13
1985 13
1986 8
1987 23
1988 19
1989 18
1990 17
1991 18
1992 20
1993 18
1994 25
1995 19
1996 37
1997 35
1998 34
1999 32
2000 34
2001 39
2002 32
2003 47
2004 44
2005 35
2006 48
2007 61
2008 57
2009 72
2010 63
2011 73
2012 65
2013 92
2014 86
2015 103
2016 100
2017 100
2018 90
2019 104
2020 114
2021 97
2022 98
2023 75
2024 75
2025 46

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,157 results

Results by year

Filters applied: . Clear all
Page 1
Glucagon-like peptide 1 (GLP-1).
Müller TD, Finan B, Bloom SR, D'Alessio D, Drucker DJ, Flatt PR, Fritsche A, Gribble F, Grill HJ, Habener JF, Holst JJ, Langhans W, Meier JJ, Nauck MA, Perez-Tilve D, Pocai A, Reimann F, Sandoval DA, Schwartz TW, Seeley RJ, Stemmer K, Tang-Christensen M, Woods SC, DiMarchi RD, Tschöp MH. Müller TD, et al. Among authors: holst jj. Mol Metab. 2019 Dec;30:72-130. doi: 10.1016/j.molmet.2019.09.010. Epub 2019 Sep 30. Mol Metab. 2019. PMID: 31767182 Free PMC article. Review.
The physiology of glucagon-like peptide 1.
Holst JJ. Holst JJ. Physiol Rev. 2007 Oct;87(4):1409-39. doi: 10.1152/physrev.00034.2006. Physiol Rev. 2007. PMID: 17928588 Free article. Review.
New therapies for obesity.
Papamargaritis D, le Roux CW, Holst JJ, Davies MJ. Papamargaritis D, et al. Among authors: holst jj. Cardiovasc Res. 2024 Feb 17;119(18):2825-2842. doi: 10.1093/cvr/cvac176. Cardiovasc Res. 2024. PMID: 36448672 Free PMC article.
Glucagon Receptor Signaling and Glucagon Resistance.
Janah L, Kjeldsen S, Galsgaard KD, Winther-Sørensen M, Stojanovska E, Pedersen J, Knop FK, Holst JJ, Wewer Albrechtsen NJ. Janah L, et al. Among authors: holst jj. Int J Mol Sci. 2019 Jul 5;20(13):3314. doi: 10.3390/ijms20133314. Int J Mol Sci. 2019. PMID: 31284506 Free PMC article. Review.
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist.
Willard FS, Douros JD, Gabe MB, Showalter AD, Wainscott DB, Suter TM, Capozzi ME, van der Velden WJ, Stutsman C, Cardona GR, Urva S, Emmerson PJ, Holst JJ, D'Alessio DA, Coghlan MP, Rosenkilde MM, Campbell JE, Sloop KW. Willard FS, et al. Among authors: holst jj. JCI Insight. 2020 Sep 3;5(17):e140532. doi: 10.1172/jci.insight.140532. JCI Insight. 2020. PMID: 32730231 Free PMC article.
Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial.
Sandsdal RM, Juhl CR, Jensen SBK, Lundgren JR, Janus C, Blond MB, Rosenkilde M, Bogh AF, Gliemann L, Jensen JB, Antoniades C, Stallknecht BM, Holst JJ, Madsbad S, Torekov SS. Sandsdal RM, et al. Among authors: holst jj. Cardiovasc Diabetol. 2023 Feb 25;22(1):41. doi: 10.1186/s12933-023-01765-z. Cardiovasc Diabetol. 2023. PMID: 36841762 Free PMC article. Clinical Trial.
ASCT2: a potential cancer drug target.
Wahi K, Holst J. Wahi K, et al. Among authors: holst j. Expert Opin Ther Targets. 2019 Jul;23(7):555-558. doi: 10.1080/14728222.2019.1627328. Epub 2019 Jun 4. Expert Opin Ther Targets. 2019. PMID: 31159623 No abstract available.
Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial.
Jensen SBK, Blond MB, Sandsdal RM, Olsen LM, Juhl CR, Lundgren JR, Janus C, Stallknecht BM, Holst JJ, Madsbad S, Torekov SS. Jensen SBK, et al. Among authors: holst jj. EClinicalMedicine. 2024 Feb 19;69:102475. doi: 10.1016/j.eclinm.2024.102475. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38544798 Free PMC article.
Somatostatin receptors.
Møller LN, Stidsen CE, Hartmann B, Holst JJ. Møller LN, et al. Among authors: holst jj. Biochim Biophys Acta. 2003 Sep 22;1616(1):1-84. doi: 10.1016/s0005-2736(03)00235-9. Biochim Biophys Acta. 2003. PMID: 14507421 Free article. Review.
2,157 results